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Interleukin (IL)-7 transgenic mice, which we established
previously, developed severe dermatitis characterized by
massive infiltration of gd T cells in the dermal lesion. To
fully understand the pathology of this intriguing skin
disease, we examined several immunologic features of
dermis infiltrating lymphocytes from the lesional skin of
IL-7 transgenic mice. We observed a moderate response
to mitogens, a poor response to alloantigens, and the
absence of cytotoxic activities to several tumor cell lines
and skin derived cells regardless of the presence of IL-2 or
IL-7. On the other hand, dermis infiltrating lymphocytes
could proliferate with exogenous IL-2 and IL-7. More-
over, reverse transcriptase polymerase chain reaction and
fluorescence activated cell sorter analysis revealed that
dermis infiltrating lymphocytes expressed various cyto-
Interleukin (IL)-7, originally identified as a pre-B cell growthfactor, is a pivotal cytokine widely involved in cell growth anddifferentiation during lymphopoiesis and myelopoiesis(Henney, 1989; Jacobsen et al, 1994). Production of IL-7 fromstromal cells of lymphoid organs of bone marrow and thymus
(Namen et al, 1988; Sakata et al, 1990), intestinal epithelial cells
(Watanabe et al, 1995), and epidermal keratinocytes (Heufler et al,
1993; Matsue et al, 1993) is one of the characteristic features that
indicates that IL-7 functions in the micromilieu of each organ in the
cell-to-cell interaction. Recently, IL-7 has been reported to play an
important role in the development of not only conventional αβ T
cells but also minor populations of γδ T cells in mice. In fact, in the
in vitro culture of fetal thymocytes (Watanabe et al, 1991) or the fetal
thymus organ culture system (Plum et al, 1993), the presence of IL-7
facilitates the appearance of γδ T cells rather than αβ T cells. IL-7 also
induced the expression and rearrangement of TcR γ gene in fetal liver
culture (Appasamy et al, 1993). Furthermore, in either IL-7 or IL-
7Rα deficient mice, the development of mature γδ T cells but not
αβ T cells was completely blocked in the thymus, spleen, liver, gut,
and skin (Moore et al, 1996; Maki et al, 1996; He and Malek,
1996). Collectively, these findings clearly demonstrate that the IL-7/
IL-7R system provides indispensable signals for γδ T cell development
and/or maintenance, at least in mice.
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kines including IL-4 and IL-7, and several activation
markers for T cells (CD44, CD69, IL-2Ra), in addi-
tion to IL-7Ra. In the sera of the affected mice, hyper
e-globulinemia was observed. These findings suggested
that dermis infiltrating lymphocytes proliferated in an
activated state in the skin lesion in an autocrine and/or
paracrine manner and produced Th2 type cytokines that
might evoke immunologic abnormalities. This study and
previous findings suggest that IL-7 transgenic mouse with
dermatitis offer the potential of serving as a useful tool
for investigating the immunologic role of cutaneous gd
T cells, especially their participation in IgE production
in vivo. Key words: cutaneous lymphocyte/gd T lymphocyte/
IgE/IL-4. J Invest Dermatol 110:740–745, 1998
In the past several years, four groups including ours established
transgenic mice constitutively producing IL-7 to investigate the in vivo
IL-7 function (Samaridis et al, 1991; Uehira et al, 1993; Rich et al,
1993; Mertsching et al, 1995). Interestingly, we noted that the dramatic
symptoms of severe dermatitis accompanied by itching behavior,
erythroderma, alopecia, lymphoadenopathy, and massive infiltration of
mononuclear cells, appeared mainly in the dermal lesion in IL-7
transgenic mice. Every transgenic mouse had the potential to develop
the dermatitis (Uehira et al, 1993). Further analysis revealed that dermis
infiltrating lymphocytes (DIL) in the lesional skin of our IL-7 transgenic
mice were composed mainly of CD4– CD8– (double negative) T cells
bearing γδ TcR other than the Vγ5 invariant chain that is predominantly
used by dendritic epidermal T cells (DETC). Although the aberrant
accumulation of γδ T cells was also observed in the spleen and lymph
node of IL-7 transgenic mice, this accumulation did not precede the
development of the dermatitis. Thus primary accumulation of γδ T
cells was hypothesized to occur in the skin. This finding led us to the
conclusion that there might be a strong relationship between the
expression of IL-7 and the development of γδ T cells in vivo, especially
in the skin (Uehira et al, 1993).
In this study, with the aim of further understanding the pathologic
characteristics and developmental mechanism of the intriguing skin
diseases observed in IL-7 transgenic mice, we studied some immuno-
logic features of DIL prepared from the lesional skin and also the
serum IgE level of IL-7 transgenic mice.
MATERIALS AND METHODS
Mice IL-7 transgenic mice (line 34) that developed dermatitis with a high
incidence and early onset were maintained by crossing transgenic mice with
C57BL/6 J mice (Clea, Tokyo, Japan) (Uehira et al, 1993). All mice were bred
and housed under clean conditions with monitoring every month to assure that
they were free of specific pathogens. The animals were treated in accordance
with the Institute’s Animal Facility Guideline.
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Reagents Concanavalin A was obtained from Pharmacia Biotech (Uppsala,
Sweden). Phytohemagglutinin-P (PHA) and lipopolysaccharide W (LPS) were
from Difco Laboratories (Detroit, MI). Recombinant mouse (rm) IL-7
(3.33 3 106 U per mg) was purchased from Genzyme (Cambridge, MA).
Recombinant human (rh) IL-2 (3.0 3 107 IU per mg, Shionogi, Osaka, Japan)
was used. The culture medium consisted of RPMI-1640 medium (Gibco BRL,
Gaithersburg, MD), 5 3 10–5 M 2-mercaptoethanol, 10 mM HEPES pH 7.4,
1000 U penicillin per ml, 10 µg streptomycin per ml, and 10% heat inactivated
fetal bovine serum (Hyclone, Logan, UT), if not otherwise mentioned.
Antibodies For analysis of DIL, the following monoclonal antibodies (MoAb)
were used. Fluoroescein isothiocyanate (FITC) conjugated anti-TcRαβ (H57–
597), FITC conjugated anti-CD44 (IM7), FITC conjugated anti-CD69 (H1.
2F3), FITC conjugated anti-IL-2Rα (7D4), and PE conjugated anti-TcRγδ
(GL-3) were purchased from PharMingen (San Diego, CA). Rat anti-IL-7Rα
(A7R34) (Sudo et al, 1993) was a gift from Dr. S. Nishikawa. FITC conjugated
goat F(ab9)2 anti-rat IgG (H 1 L) (Caltag Laboratories, San Francisco, CA) was
used as the second antibody when staining was done with anti-IL-7Rα.
Preparation of DIL DIL were obtained from dermatitis-affected skin of
IL-7 transgenic mice according to the method described in a previous paper
(Uehira et al, 1993) with minor modification. Briefly, skins with dermatitis
lesions were removed, and freed of subcutaneous tissue and lymph nodes. The
neat skins were cut into µ3 mm wide ribbons and treated at 37°C for 3 h
with 1500 PU dispase per ml (type 1, crystalline enzyme; Godo Shusei, Tokyo,
Japan) in culture medium supplemented with 200 µg Cefaclor (Shionogi) per
ml. Swollen dermis samples were peeled off the epidermis sheets with tweezers,
and then cut into µ3 mm square pieces. For this study, the following procedures
were performed next. Each dermis piece was incubated with 2 ml of culture
medium per well in a 48 well plate (Becton Dickinson, Flanklin Lakes, NJ) at
37°C 5% CO2 for 3 d. During this period, most of the infiltrated cells emigrated
to the bottom of the culture wells from the dermis blocks. The emigrated cells
were harvested and used as DIL. The characteristic features of the collected
cells demonstrated that they consisted of lymphocytes (see Fig 4). DIL were
independently prepared from the severely affected skin of mice at 10–20 wk
of age.
Preparation of skin derived cells Skins from normal C57BL/6 J mice were
treated with dispase and peeled into epidermis and dermis parts as mentioned
above. Dissociated dermal cells and epidermal cells were harvested by squeezing
the separated skin parts. The cells were incubated with 0.25 mg DNase I
(Sigma, St. Louis, MO) per ml in Hank’s medium at room temperature for
30 min and washed three times. To recover cell surface molecules that might
have been damaged by the dispase treatment, the cells were incubated with
culture medium on a Teflon® Erlenmeyer flask (Sanplatec, Osaka, Japan) at
37°C for 20 h in 5% CO2 and 95% humidified air and then harvested for the
cytotoxic assay.
Proliferation assay to cytokines Aliquots (0.2 ml) of DIL suspension
(2 3 104 cells) were incubated with 0.1–10 ng rhIL-2 per ml and/or rmIL-7
in a flat microtest plate (Becton Dickinson) at 37°C in 5% CO2 for 1–8 d. The
cells were pulsed with 9.25 KBq of tritiated thymidine ([3H]Tdr) for the last
8 h of culture, and then harvested. Thymidine incorporation was counted by
TopCounter (Packard, Meriden, CT). The determinants were done in triplicate
and the mean 6 SD was calculated.
Mitogen and mixed lymphocyte reaction assay Aliquots (0.2 ml) of DIL
or spleen cells (2–10 3 104 cells) were stimulated with 2 µg Concanavalin A
per ml, 20 µg PHA per ml, 20 µg LPS per ml, or 1 3 105 mitomycin C
(MMC) treated spleen cells of BALB/C, C3H/He, or C57BL/6 mice, in
culture medium supplemented with 5% heat inactivated serum of C57BL/6
mice instead of 10% fetal bovine serum on a flat microtest plate (Becton
Dickinson). The cells were cultured for 2 d (Concanavalin A and PHA), 3 d
(LPS), or 4 d (MMC treated spleen cells) at 37°C in 5% CO2, pulsed with
9.25 KBq of [3H]Tdr for the last 18 h of culture, and harvested to count
radioactivity as mentioned above. MMC treated spleen cells were prepared by
incubating 5 3 106 cells in 1 ml culture medium in the presence of 50 µg
MMC at 37°C for 30 min and then washing four times. Data are expressed as
mean 6 SD from triplicate cultures.
Cytotoxicity assay Aliquots (0.1 ml) of DIL or spleen cell (effector)
suspensions (1–8 3 105 cells per well) were mixed with 0.1 ml suspension of
51Cr labeled tumor cells (2 3 104 cells per well) in a 96 well U bottomed
plate, and the cell mixture was incubated for 4 h at 37°C. Aliquots (0.1 ml) of
the culture supernatants were withdrawn and applied to a TopCounter (Packard)
to measure the 51Cr release cpm. To see the effect of cytokines on the
cytotoxicities of effector cells, DIL and spleen cells were preincubated with IL-
2 (20 ng per ml) or IL-7 (20 ng per ml) in a 24 well plate at 37°C for 6 d
under 5% CO2 and then subjected to the cytotoxicity test. For
51Cr labeling,
5 3 106 tumor cells of YAC-1 (H-2a), P815 (H-2d), EL4 (H-2b), MethA (H-
2d), or skin derived cells were incubated with 1.85 MBq of sodium chromate
[51Cr] solution (Amersham, Tokyo, Japan) in 1 ml of culture medium at 37°C
for 2 h. The washed cells served as 51Cr labeled target cells. The percentage of
target cell lysis was calculated from the following equation:
cpm of sample lysis — cpm of background lysis
% specific lysis 5 100 3
cpm of total lysis — cpm of background lysis
Here, the background lysis derived from the culture supernatants without
effector cells and the total lysis were obtained from the supernatants of 51Cr
labeled target cells lyzed with a detergent solution. The determinants were
done in triplicate and the mean 6 SD was calculated. The mean values dropped
to below zero (the maximum drop being –4%) in some cases. Therefore, the
points that were less than 14% were regarded as nonsignificant values in this
study. In the case of percentage specific lysis at below zero, they were marked
at the zero point.
Detection of cytokine mRNA expression The reverse transcriptase poly-
merase chain reaction (PCR) was performed as previously described (Uehira
et al, 1993). Briefly, total cellular RNA of freshly prepared DIL was isolated by
TRIZOL (Gibco BRL) according to the manufacturer’s instructions. Prior to
first-strand cDNA synthesis, total cellular RNA (1.75 µg) was treated with
sufficient RNase-free DNaseI (3 U) (Gibco BRL) at room temperature for
15 min to prevent amplification from DNA as impurities. After inactivation of
DNaseI by adding ethylenediamine tetraacetic acid and heating at 65°C for
15 min, the RNA sample was subjected to first-strand cDNA synthesis by
SUPER SCRIPT II (Gibco BRL) using a random hexamer mix. After RNaseH
(Gibco BRL) treatment, these synthesized cDNA samples were pooled, divided
into 14 aliquots, and subjected to PCR. Amplification for the detection of
specified genes was performed in a 25 µl reaction mix containing 0.2 mM of
each dNTP, 10 mM Tris (pH 8.3), 50 mM KCl, 2 mM MgCl2, 1.0 U of Taq
DNA polymerase (AMPLI TAQ; Perkin-Elmer Cetus, Norwalk, CT), and
0.4 µM of forward and reverse primers. Thirty-five cycles were run for 45 s at
94°C, 45 s at 60°C, 2 min at 72°C per cycle for all genes but annealed at 55°C
instead of 60°C for endogenous and transgenic IL-7 genes. A denaturation step
at 94°C for 1 min before the first cycle and an extension step at 72°C for
7 min after the thirty-fifth cycle were adopted. To eliminate signals from
nonspecific PCR products, the amplified products were analyzed by Southern
blot hybridization technique using oligonucleotide probes end labeled with 32P
as described elsewhere (Sambrook et al, 1989). Autoradiograms were generated
to expose to New RX X-ray films (Fuji Photo Film, Tokyo, Japan) for 1 h at
room temperature.
The primers specific for IL-1α, IL-2, IL-3, IL4, IL-5, IL-6, IL-10, interferon
(IFN)-γ, granulocyte macrophage colony stimulating factor, tumor necrosis
factor (TNF)-β, and glyceraldehyde 3-phosphate dehydrogenase (G3PDH),
and the oligonucleotide probes specific for all of them but G3PDH. were
purchased from Clontech (MAPPING amplimers and Cytokine Probes, Palo
Alto, CA). For the detection of endogenous IL-7 gene expression, forward
primer (IL-7/5: 59-dGCTGCAGTCCCAGTCATCAT-39) and reverse primer
(IL-7/2: 59-dAGCTTCCTTTGTATCATCAC-39) were used. For the detec-
tion of transgenic IL-7 gene expression, forward primer (IL-7/5) and reverse
primer (SKU: 59-dCTCTAGAACTAGTGGATCCC-39) were used. For
Southern analysis of G3PDH and both IL-7 genes, G3PDH probe (G3P: 59-
dACGACGGACACATTGGGGGTAGGAACACGG-39) and IL-7 probe
(IL-7/4: 59-dGTGGCACTCAGATGATGTGACA-39) were used, respectively.
Flow cytometric analysis Single cell suspensions of DIL (0.5–1 3 106) cells
were stained with excess MoAb for 20 min at 4°C in 40 µl of phosphate
buffered saline containing 1% bovine serum albumin and 0.1% sodium azide.
The cells were then washed three times with Hank’s solution containing 0.1%
sodium azide at 4°C. Subsequently, if necessary, the cells were stained with a
FITC conjugated goat F(ab9)2 anti-rat IgG (H 1 L) for 20 min at 4°C and
washed three times. Viable cells were gated on forward light scatter, side light
scatter, and 7-aminoactinomycin D exclusion, and measured by double-color
flow cytometry with a FACScan (Becton Dickinson). The acquired data from
10,000 events were analyzed with FACScan Research Software (Becton
Dickinson).
Some T cell surface antigens were reported to be weakened by enzymatic
treatment during single cell preparation (Mulder et al, 1994). Indeed, if they
were measured just after dispase treatment, the fluorescence intensity of TcR
αβ, TcR γδ, CD44, and IL-2Rα on DIL significantly reduced the level in
comparison with that prepared by a nonenzymatic squeezing method (data not
shown); however, 3 d culture after dispase treatment, which was employed to
prepare DIL, restored the fluorescence intensity to levels indistinguishable from
that of DIL prepared nonenzymatically.
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Figure 1. DIL can proliferate in response to IL-7 and/or IL-2. DIL
were obtained independently from two transgenic mice with dermatitis. DIL
suspensions (2 3 104 cells per 0.2 ml per well) were incubated with 0.1, 1.0,
or 10 ng per ml of IL-2 or/and IL-7 for the indicated number of days.
Thymidine incorporation was done for the last 8 h of cultures. Values were
presented as mean 6 SD of triplicate cultures. u, Control; e, 0.1 ng per ml;
s, 1.0 ng per ml; n, 10 ng per ml.
Measurements of serum IgE levels Serum IgE levels were determined by
a sandwich enzyme linked immunosorbent assay method. Briefly, 96 wells of a
microplate (Nunc, Roskilde, Denmark) were coated with 50 µl anti-mouse
IgE MoAb (Yamasa, Choshi, Japan) at 4 µg per ml in Dulbecco’s phosphate
buffer [PBS(–)] overnight at 4°C. After washing, the wells were blocked with
0.1% bovine serum albumin (crystallized grade; Miles, Kankakee, IL). Next,
a total volume of 50 µl diluted test serum was added per well. After 1 h
incubation at room temperature, the wells were washed, and then 50 µl of
mixture of 1/100 diluted biotinylated rat anti-mouse IgE MoAb (Meiji, Tokyo,
Japan) and 1/300 diluted streptavidin labeled alkaline phosphatase (BioSource
International, Camarillo, CA) were added and incubated for 1 h at room
temperature. After washing five times, 50 µl p-nitro-phenylphosphate substrate
(Zymed, San Francisco, CA) solution was added to each well and the absorbance
at 405 nm was read with an enzyme linked immunosorbent assay reader
(MULTISKAN Biochromatic; Labsystems, Helsinki, Finland). Purified mouse
anti-DNP IgE protein (Yamasa) was used as the standard.
RESULTS
Proliferative response of DIL to cytokines, mitogens, or
allogenic splenocytes To observe the proliferation effect of cyto-
kines, DIL were cultured with various doses of IL-2 and/or IL-7 for
the indicated number of days. Figure 1 shows that DIL displayed a
good response to IL-2 with respect to dose dependency in the range
of 1.0–10 ng per ml with the peak at 2–3 d of culture (Fig 1a, d). IL-
7 was also a good stimulus for DIL, producing almost the same response
patterns as IL-2, although the [3H]thymidine uptake was lower (Fig 1b,
e). The higher the dose, the longer was the proliferation period for
both cytokines. Addition of more than 10 ng cytokine per ml led to
almost the same [3H] incorporation as at 10 ng per ml for both IL-2
and IL-7 (data not shown). The additive effect was observed when
IL-2 and IL-7 were combined at 1.0 or 10 ng per ml dose (Fig 1c,
f ). The proliferative response to IL-7 of DIL in vitro suggested that
the aberrant expression of IL-7 in transgenic mice directly influenced
the appearance of DIL in vivo as well. IL-2 could also evoke the
proliferative effect on DIL in vitro.
DIL could moderately proliferate in response to mitogenic stimuli
such as Concanavalin A and PHA as compared with spleen cells from
normal mice, whereas LPS provoked little mitogenic response of these
DIL (Table IA). The result that DIL could respond mainly to
Concanavalin A and PHA but not LPS was in agreement with our
finding that most DIL consisted of T cells (Uehira et al, 1993).
Next, we conducted a mixed lymphocyte reaction test of DIL
Figure 2. Cytotoxic activity of DIL to tumor cell lines and skin
derived cells is absent. DIL from affected mice or spleen cells from normal
mice were not treated or were treated with 20 ng IL-2 per ml or 20 ng IL-7
per ml for 6 d, and then used as effector cells. Their cytotoxic activities to
target cells were measured by 51Cr release assay and calculated as percentage
specific lysis as described in Materials and Methods. The mean values dropped to
below zero in some cases (the maximum drop being –4%). Therefore, the
points that showed less than 14% were regarded as nonsignificant values in
this study. In the case of percentage specific lysis at below zero, they were
marked at zero point. Values were presented as mean 6 SD of triplicate
cultures. (a–f) Symbols for tumor cell lines used as target cells were as follows:
u, YAC-1; e, P815; d, EL-4; m, Meth-A. (g–i) Symbols for skin derived
cells used as target cells were as follows: i, epidermal cells; s, dermal cells.
(H-2b) as responder cells to allogenic spleen cells (H-2d or H-2k). As
shown in Table IB, nonsignificant proliferative responses to both
allogenic and syngenic spleen cells were observed for DIL.
Absence of cytotoxic activity of DIL to tumor cell lines and
skin derived cells IL-7, as well as IL-2, can induce lymphokine
activated killer (LAK) activity of spleen and lymph node cells to a
broad spectrum of target tumor cells in addition to natural killer
sensitive YAC-1 cells (Stotter et al, 1991; Schadendorf et al, 1994).
Because increased IL-7 activity was detected in the sera of IL-7
transgenic mice with dermatitis (Uehira et al, 1993), DIL might acquire
LAK like activity in vivo. Thus, it would be intriguing to investigate
whether DIL can kill some tumor cell lines in vitro with or without
cytokine stimuli. To address this issue, we measured the killing activity
of nontreated or lymphokine stimulated DIL to target cells by 51Cr
release test (Fig 2).
To confirm that the cytotoxic assay was effective, natural killer and
LAK activities of normal spleen cells from C57BL/6 mice were
examined. Figure 2(a, b) showed that normal spleen cells had natural
killer activity against YAC-1 cells and 6 d treatment with IL-2 induced
LAK activity against four different tumor cell lines. Moreover, the
treatment of spleen cells with IL-7 induced LAK activities (Fig 2c),
which was consistent with the findings of other researchers (Stotter
et al, 1991; Schadendorf et al, 1994). On the other hand, the values of
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Table I. Proliferative response of DIL to mitogens or allogenic splenocytes
Case no.a[3H] Thymidine uptake [cpm (stimulation index)b]
(A) Mitogen response Medium Concanavalin A PHA LPS
DIL 1 132 6 39 5096 6 1033 (38.6) 1948 6 287 (14.8) 197 6 44 (1.5)
2 84 6 22 2073 6 136 (24.5) 1858 6 289 (22.1) 115 6 19 (1.4)
Normal spleen cells 261 6 45 31,627 6 4164 (121.1) 18,817 6 827 (72.1) 19,581 6 1913 (75.0)
(B) Mixed lymphocyte reaction Medium BALB/C-MMC (H-2d) C3H-MMC (H-2 k) C57BL/6-MMC (H-2b)
DIL 3 1782 6 835 2167 6 702 (1.2) 1564 6 479 (0.9) 897 6 98 (0.5)
4 1369 6 628 1860 6 223 (1.4) 1529 6 367 (1.1) 1089 6 276 (0.8)
5 4173 6 1049 5847 6 1369 (1.4) 8377 6 3514 (2.0) 2956 6 659 (0.7)
6 2824 6 1627 3204 6 490 (1.1) 1903 6 555 (0.7) 1648 6 435 (0.6)
Normal spleen cells 327 6 40 3652 6 1834 (11.2) 2805 6 558 (8.6) 182 6 23 (0.6)
aCase no. indicates the source of DIL obtained from independent transgenic mouse with dermatitis.
bStimulation index denotes the value of mean cpm with various stimuli divided by mean cpm without stimulation. DIL were used as follows: (A) 2 3 104 in cases 1 and 2, (B) 4 3 104
in cases 3 and 4, 1 3 105 in cases 5 and 6. Normal spleen cells from C57BL/6 J mice were used at 1 3 105 as the control. MMC (mitomycin C) treated spleen cells were 1 3 105.
Values shown are mean 6 SD from triplicate cultures.
percentage specific lysis by DIL were less than 4% at any determinant
point. This meant that DIL without cytokine treatment showed no
cytotoxic activity even to YAC-1 (Fig 2d), and that the treatment of
DIL with either IL-2 or IL-7 for 6 d evoked no cytotoxic activities
to any tumor cell lines (Fig 2e, f ). DIL culture of 4–7 d with IL-2 or
IL-7 also showed no sign of killing these target cells (data not shown).
Thus DIL did not acquire the cytotoxic activity despite the cytokine
stimulation in vivo or in vitro.
It is important to know if DIL has killing activity against the cellular
components of skin as an autoimmune inflammatory response or not.
Therefore, cytotoxic activities of DIL to skin derived cells that had
been freshly isolated from normal mouse skin were investigated. No
significant levels of cytotoxic activity of DIL to the epidermis or
dermis derived cells were observed even with pretreatment of DIL
with IL-2 or IL-7 (Fig 2h, i ). Thus DIL did not acquire cytotoxic
activity to syngenic skin derived cells as far as detectable by short term
(4 h 51Cr released) assay.
Expression of Th2 type rather than Th1 type cytokine mRNA
in DIL The expression of mRNA for various cytokines in DIL
was examined by reverse transcriptase PCR method combined with
Southern hybridization to exclude the nonspecific signals. Significant
signals of amplified products including IL-1α, IL-2, IL-4, IL-5, IL-6,
endogenous IL-7, transgenic IL-7, IL-10, granulocyte macrophage
colony stimulating factor, and TNF-β were detected in DIL from
independent mice, whereas only a faint signal of IL-3 and a weak
signal of IFN-γ were detected (Fig 3). As DIL were prepared without
addition of any stimulant for cytokine induction, these cytokine
expressions may reflect the in vivo status of DIL. Thus, this cytokine
profile implied that DIL were proliferating in an activated state in
lesional skin, and the inflammatory reaction might occur as a result.
Although the expression of mRNA could not be quantitatively
evaluated by the conventional reverse transcriptase PCR employed in
this study, our finding with transgenic mice that DIL expressed IL-4,
IL-5, IL-6, and IL-10 of Th2 type cytokine mRNA, rather than
IFN-γ of Th1 type cytokine mRNA, offers support for the
superiority of the Th2 mediated immune reaction as classified by
Mosmann and Coffman (1989); however, because DIL also expressed
IL-2 and TNF-β that were predominantly produced by murine Th1
type cells, DIL could not be clearly classified as a Th1 or Th2 type
cell. From the viewpoint of the cytokine expression profile, DIL may
be a heterogeneous population consisting of a mixture of a major
population of Th2 type cells and a minor population of Th1 type cells.
Elevated expression of surface activation markers on DIL We
previously reported that most of the DIL consisted of γδ T cells
without expression of CD4 and CD8, called double negative (Uehira
et al, 1993). To define further phenotypic features of DIL, we performed
fluorescence activated cell sorter analysis using various MoAb. Figure 4
Figure 3. Th2 type cytokine mRNA are predominantly detected in
DIL by reverse transcriptase PCR method. The expression of cytokines
in DIL was examined by reverse transcriptase PCR method followed by
Southern blot hybridization as mentioned in Materials and Methods. PCR
was carried out at 35 cycles using the indicated primers. Lanes 1 and 2 of
each panel contain the PCR product from DIL of independent transgenic
mouse with dermatitis. Horizontal bars show the theoretical size of the
PCR product amplified by each set of primers. G3PDH and RT (–) were
performed with the same protocol as positive or negative controls, respectively,
except for nontreatment with reverse transcriptase in the first-strand cDNA
synthesis of RT (–).
presents the representative fluorescence activated cell sorter profile for
more than 10 cases of DIL, showing that more than 90% of DIL was
stained with anti-pan γδ TcR MoAb, whereas only a small portion
was stained with anti-pan αβ TcR MoAb. A trace of B220 positive
cells was also detectable (data not shown). This fully agreed with our
previous finding. Among the several activation markers examined,
elevated expression of CD44 and IL-2Rα, which are usually detected
on activated T cells (Budd et al, 1987; Morrissey et al, 1989), was
observed for all populations of DIL. Thus the minor population of αβ
T cells present in DIL also expressed CD44 and IL-2Rα. Likewise,
expression of CD69 that is a rapidly induced T cell activation Ag
(Yokoyama et al, 1988) was observed on most but not all DIL. Thus,
most of the DIL were CD441 CD691 IL-2Rα1 double negative γδ
T cells, and these features indicate that most are activated within the
skin lesion. This is also supported by the finding of the expression of
various cytokines in DIL. Moreover, in addition to IL-2Rα, IL-7Rα
was also expressed on the surface of all DIL. In fact, DIL could
proliferate in the response to IL-2 and IL-7, and express both cytokines
(Figs 1, 3). Therefore, DIL may proliferate in an autocrine and/or
paracrine manner in response to both IL-2 and IL-7 produced by DIL
themselves in the lesional skin of IL-7 transgenic mice.
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Figure 4. Surface activation markers are detected on DIL by flow
cytometric analysis. DIL were stained with FITC conjugated anti-TcRαβ
(H57–597), PE conjugated anti-TcRγδ (GL-3), FITC conjugated anti-CD44
(IM7), FITC conjugated anti-CD69 (H1. 2F3), FITC conjugated anti-IL-2Rα
(7D4), or anti-IL-7Rα (A7R34) MoAb followed by FITC conjugated goat
F(ab9)2 anti-rat Ig G antibodies. The dotted line indicates the unstained control
(all but anti-IL-7Rα MoAb) or FITC conjugated goat F(ab9)2 anti-rat IgG
antibodies staining without anti-IL-7Rα MoAb staining. The value in the
upper right corner is the percentage of positive cells for each MoAb indicated.
Data shown are representative of one of three experiments.
High levels of serum IgE in dermatitis mice IgE synthesis has
been demonstrated to be regulated by IL-4 both in vitro and in vivo
(Snapper et al, 1988; Burstein et al, 1991). Because of the significant
signal of IL-4 mRNA expression observed in the DIL preparation
from dermatitis mice, the levels of serum IgE in IL-7 transgenic mice
were examined (Fig 5). Although these levels in mice without
dermatitis were within those of nontransgenic mice, most cases of
dermatitis transgenic mice (eight of nine females and five of seven
males) revealed excessively high levels of serum IgE. The findings that
none of the transgenic mice without dermatitis had high IgE levels,
whereas the IgE levels of some mice with dermatitis remained normal,
suggested that the onset of elevated levels of IgE would not temporally
precede the appearance of grossly recognizable dermatitis.
Because one of the major differences between nondermatitis and
dermatitis mice was the presence of DIL in the latter, DIL may be
responsible for the elevated levels of serum IgE.
DISCUSSION
We previously reported that IL-7 transgenic mice developed severe
dermatitis showing distinctive symptoms and histopathologic features,
such as intense pruritus, generalized erythroderma, alopecia, lympho-
adenopathy, and prominent dermis infiltration by γδ T cells (Uehira
et al, 1993). In this study, we investigated several immunologic features
of DIL that mainly consist of γδ T cells accumulated in the lesional
dermis to try to further understand the pathologic characteristics
and developmental mechanism of this skin disease. Regarding the
proliferative response to various stimuli, DIL showed a moderate
response to mitogens and a poor response to allogenic antigens, whereas
the exogenous IL-2 or IL-7 provoked a proliferative response of DIL.
This cytokine dependency of DIL and our previous finding of the
Figure 5. Serum IgE levels are elevated in IL-7 transgenic mice with
dermatitis. Serum IgE levels of each mouse (7–20 wk of age) were assayed
by the enzyme linked immunosorbent assay system. The determinants were
plotted for the groups of nontransgenic (N), transgenic without dermatitis (Tg),
and transgenic with dermatitis (TgD) mice of either sex. Numbers in parentheses
indicate the number of mice in each group. The mean values 6 SD of age
(wk) of mice in each group were as follows: female, 14.1 6 3.1 (N), 12.9 6 3.1
(Tg), and 16.3 6 3.7 (TgD); male, 14.5 6 0.7 (N), 13.3 6 5.3 (Tg), and
12.1 6 5.5 (TgD). The hatched levels in the panels indicate the 3-fold values
of SD among nontransgenic mice. Eight of nine female mice and five of seven
male mice showed excessively high levels of serum IgE.
elevated level of serum IL-7 in transgenic mice supported the hypothesis
of aberrant expression of IL-7 directly promoting the appearance of
DIL and the development of dermatitis in transgenic mice. Moreover,
the findings that the presence of IL-7 plus IL-2 could elicit the
additive proliferative response of DIL in vitro and that the set of IL-7,
IL-2, IL-7R, and IL-2R was expressed by DIL itself, strongly suggested
that DIL grew in vivo in an autocrine and/or paracrine manner;
however, in spite of autonomous production of IL-7 and IL-2, DIL
could not proliferate without exogenous addition of cytokines in vitro
(Fig 1). Further induction or accumulation of IL-7 or IL-2 in skin
might be required for DIL proliferation in vivo. In fact, DIL could
proliferate and provoke similar symptoms with the affected transgenic
mice in the skin of recipient normal mice by injection into the tail
vein without administration of any cytokines (data not shown).
In normal mice, the various γδ T cell subsets reside in different
tissues with the preferential receptor usage of Vγ gene segments with
or without the junctional diversity, and the reactivities of each γδ T
cell subset, γδ T cell clones, or γδ T cell hybridomas to different
immunologic stimuli have been reported as being varied (Raulet, 1989;
Haas et al, 1993). With a focus on γδ T cells residing in skin, it has
been reported that there were separate γδ T cell populations within
the murine epidermis or dermis. Among them, DETC bearing a
monoclonal Vγ5/Vδ1 TcR specific for a keratinocyte stress induced
antigen have been well studied (Havran et al, 1991). On the other
hand, a distinct population of γδ T cells, which is distinguishable from
DETC, has been found in the dermis region of normal mice with its
growth supported by IL-7 (Nakagawa et al, 1993; Tamaki et al, 1996);
however, the immunologic and physiologic roles of dermal γδ T cells
have not yet been clarified. The fact that DIL expressed TcR other
than the Vγ5 chain and mainly proliferated within the dermis (Uehira
et al, 1993), suggested that DIL originated from dermal or other γδ T
cells rather than DETC. In some cases other than skin tissue, γδ T
cells have been shown to lyse target tumor cells (Borst et al, 1987;
Brenner et al, 1987; Goodman and Lefrancois, 1988), because natural
killer cells or LAK cells can kill them; however, DIL did not acquire
the cytotoxic activity to the tumor cell line or the skin derived cells
despite cytokine stimulation in vivo or in vitro. This result suggests that
the dermatitis is not caused by direct killing of skin cells. Regarding
the tissue specificity of DIL, there are some other possibilities including
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a proliferative response to skin derived antigens or the involvement of
chemoattractants or adhesion molecules in a skin specific manner.
These possibilities are currently under investigation.
It is intriguing to inquire into the mechanism(s) causing immuno-
logic abnormalities, including a moderate response to mitogens, a poor
response in mixed lymphocyte reaction, the absence of cytotoxic
activity to tumor cell lines, and an increased serum IgE level in
dermopathic IL-7 transgenic mice. In this regard, our finding that DIL
express IL-4 rather than IFN-γ mRNA is very interesting. IL-4 is a
multifunctional cytokine that has a potent effect on cells of virtually
all hematopoieic lineages (Paul and Ohara, 1987). Interestingly, IL-4
has been reported to have various in vitro effects, which are similar to
the observations in this study, including a decreased mitogenic response,
a decreased natural killer and LAK cell activity, and an increased level
of IgE (Vowels et al, 1992). Therefore, the preferential production of
IL-4 by DIL may be one of the factors leading to the abnormal
immunologic features of DIL themselves and dermatitis mice. There
are some very interesting reports that offer evidence that IL-7 stimulates
the induction of IL-4 activity (Stotter et al, 1991; Dokter et al, 1994;
Webb et al, 1997). Thus, the presence of aberrant IL-7 might directly
facilitate the appearance of DIL producing IL-4 in transgenic mice.
On the other hand, IL-2 and TNF-β expressions by DIL suggest a
host-defense reaction of Th1 type cells against proliferating Th2 type
cells. Severe dermatitis in IL-7 transgenic mice is usually accompanied
by symptoms of erythroderma and thickened epidermis and dermis,
indicating that the inflammatory reaction might occur in the skin
lesions. The results of mRNA expression of various inflammatory
cytokines, including IL-1α, IL-5, IL-6, granulocyte macrophage colony
stimulating factor, and TNF-β, and the presence of surface activation
markers, offer support for DIL proliferation in an activated state in
lesional skin and the resulting progression of the inflammatory reaction.
Studying what activates the DIL should promote understanding of not
only the pathogenesis of IL-7 transgenic mice but also the immunologic
role of cutaneous γδ T cells, especially their participation in IgE
production in vivo.
We thank Dr. S. Nishikawa for a generous gift of MoAb and Dr. K. Tamaki for
critical comments.
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